Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3354687
Max Phase: Preclinical
Molecular Formula: C31H43N9O5S
Molecular Weight: 653.81
Molecule Type: Protein
Associated Items:
ID: ALA3354687
Max Phase: Preclinical
Molecular Formula: C31H43N9O5S
Molecular Weight: 653.81
Molecule Type: Protein
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)c1nc2ccccc2s1
Standard InChI: InChI=1S/C31H43N9O5S/c1-18(37-29(45)24(8-4-5-15-32)39-28(44)21(33)17-19-11-13-20(41)14-12-19)27(43)38-23(9-6-16-36-31(34)35)26(42)30-40-22-7-2-3-10-25(22)46-30/h2-3,7,10-14,18,21,23-24,41H,4-6,8-9,15-17,32-33H2,1H3,(H,37,45)(H,38,43)(H,39,44)(H4,34,35,36)/t18-,21-,23-,24-/m0/s1
Standard InChI Key: YIQJMJSYXAKORA-OPEMAFOOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 653.81 | Molecular Weight (Monoisotopic): 653.3108 | AlogP: 0.62 | #Rotatable Bonds: 18 |
Polar Surface Area: 251.43 | Molecular Species: BASE | HBA: 10 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.42 | CX Basic pKa: 11.58 | CX LogP: -0.13 | CX LogD: -4.84 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.04 | Np Likeness Score: -0.09 |
1. Duchêne D, Colombo E, Désilets A, Boudreault PL, Leduc R, Marsault E, Najmanovich R.. (2014) Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2., 57 (23): [PMID:25387268] [10.1021/jm5015633] |
Source(1):